UnitedHealthCare Group (UNH-NYSE, $291.71) and Novo Nordisk (NVO-NYSE, $64.37) Change Their CEOs in the Same Week.

UnitedhealthCare Group and Novo Nordisk investors have been shocked at the 42.3% and 26.5% share price implosion in 2025. Headline issues at UnitedHealth revolve around a trial of a murdered key executive at the insurance division, most recently the unceremonious

Posted in Open Blog

published about 1 month ago




See all items from the same source